83 FR 60898 - Bulk Manufacturer of Controlled Substances Application: Noramco Inc.
DEPARTMENT OF JUSTICE
Drug Enforcement Administration Federal Register Volume 83, Issue 228 (November 27, 2018)
Drug Enforcement Administration
Federal Register Volume 83, Issue 228 (November 27, 2018)
| Page Range | 60898-60898 | |
| FR Document | 2018-25874 |
[Federal Register Volume 83, Number 228 (Tuesday, November 27, 2018)] [Notices] [Page 60898] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2018-25874] ----------------------------------------------------------------------- DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA-392] Bulk Manufacturer of Controlled Substances Application: Noramco Inc. ACTION: Notice of application. ----------------------------------------------------------------------- DATES: Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before January 28, 2019. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Assistant Administrator of the DEA Diversion Control Division (``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0, appendix to subpart R. In accordance with 21 CFR 1301.33(a), this is notice that on July 4, 2018, Noramco Inc., 1550 Olympic Dr. Athens, Georgia 30601 applied to be registered as a bulk manufacturer for the basic classes of controlled substances: ------------------------------------------------------------------------ Controlled substance Drug code Schedule ------------------------------------------------------------------------ Cathinone....................... 1235 I Gamma Hydroxybutyric Acid....... 2010 I Marihuana....................... 7360 I Tetrahydrocannabinols........... 7370 I Codeine-N-oxide................. 9053 I Dihydromorphine................. 9145 I Hydromorphinol.................. 9301 I Morphine-N-oxide................ 9307 I Amphetamine..................... 1100 II Lisdexamfetamine................ 1205 II Methylphenidate................. 1724 II Nabilone........................ 7379 II Codeine......................... 9050 II Dihydrocodeine.................. 9120 II Oxycodone....................... 9143 II Hydromorphone................... 9150 II Hydrocodone..................... 9193 II Morphine........................ 9300 II Oripavine....................... 9330 II Thebaine........................ 9333 II Opium tincture.................. 9630 II Oxymorphone..................... 9652 II Noroxymorphone.................. 9668 II Alfentanil...................... 9737 II Sufentanil...................... 9740 II Carfentanil..................... 9743 II Tapentadol...................... 9780 II Fentanyl........................ 9801 II ------------------------------------------------------------------------ The company plans to manufacture bulk active pharmaceutical ingredients (APIs) and reference standards for distribution to their customers. In reference to drug codes 7360 (marihuana) and 7370 (tetrahydrocannabinols), the company plans to bulk manufacture these drugs as synthetic. No other activities for these drug codes are authorized for this registration. Dated: November 16, 2018. John J. Martin, Assistant Administrator. [FR Doc. 2018-25874 Filed 11-26-18; 8:45 am] BILLING CODE 4410-09-P
![60898 Federal Register / Vol. 83, No. 228 / Tuesday, November 27, 2018 / Notices
The company plans to import the listed DATES: Registered bulk manufacturers of respect to the promulgation and
controlled substances for analytical the affected basic classes, and implementation of 21 CFR part 1301,
research, testing and clinical trials. applicants therefore, may file written incident to the registration of
Dated: November 16, 2018. comments on or objections to the manufacturers, distributors, dispensers,
John J. Martin, issuance of the proposed registration on importers, and exporters of controlled
or before January 28, 2019. substances (other than final orders in
Assistant Administrator.
[FR Doc. 2018–25869 Filed 11–26–18; 8:45 am] ADDRESSES: Written comments should connection with suspension, denial, or
be sent to: Drug Enforcement revocation of registration) has been
BILLING CODE 4410–09–P
Administration, Attention: DEA Federal redelegated to the Assistant
Register Representative/DPW, 8701 Administrator of the DEA Diversion
DEPARTMENT OF JUSTICE Morrissette Drive, Springfield, Virginia Control Division (‘‘Assistant
22152. Administrator’’) pursuant to section 7 of
Drug Enforcement Administration 28 CFR part 0, appendix to subpart R.
SUPPLEMENTARY INFORMATION: The
[Docket No. DEA–392] Attorney General has delegated his In accordance with 21 CFR
authority under the Controlled 1301.33(a), this is notice that on July 4,
Bulk Manufacturer of Controlled Substances Act to the Administrator of 2018, Noramco Inc., 1550 Olympic Dr.
Substances Application: Noramco Inc. the Drug Enforcement Administration Athens, Georgia 30601 applied to be
(DEA), 28 CFR 0.100(b). Authority to registered as a bulk manufacturer for the
ACTION: Notice of application.
exercise all necessary functions with basic classes of controlled substances:
Controlled substance Drug code Schedule
Cathinone ................................................................................................................................................................ 1235 I
Gamma Hydroxybutyric Acid ................................................................................................................................... 2010 I
Marihuana ................................................................................................................................................................ 7360 I
Tetrahydrocannabinols ............................................................................................................................................ 7370 I
Codeine-N-oxide ...................................................................................................................................................... 9053 I
Dihydromorphine ..................................................................................................................................................... 9145 I
Hydromorphinol ....................................................................................................................................................... 9301 I
Morphine-N-oxide .................................................................................................................................................... 9307 I
Amphetamine .......................................................................................................................................................... 1100 II
Lisdexamfetamine ................................................................................................................................................... 1205 II
Methylphenidate ...................................................................................................................................................... 1724 II
Nabilone .................................................................................................................................................................. 7379 II
Codeine ................................................................................................................................................................... 9050 II
Dihydrocodeine ........................................................................................................................................................ 9120 II
Oxycodone .............................................................................................................................................................. 9143 II
Hydromorphone ....................................................................................................................................................... 9150 II
Hydrocodone ........................................................................................................................................................... 9193 II
Morphine .................................................................................................................................................................. 9300 II
Oripavine ................................................................................................................................................................. 9330 II
Thebaine .................................................................................................................................................................. 9333 II
Opium tincture ......................................................................................................................................................... 9630 II
Oxymorphone .......................................................................................................................................................... 9652 II
Noroxymorphone ..................................................................................................................................................... 9668 II
Alfentanil .................................................................................................................................................................. 9737 II
Sufentanil ................................................................................................................................................................. 9740 II
Carfentanil ............................................................................................................................................................... 9743 II
Tapentadol ............................................................................................................................................................... 9780 II
Fentanyl ................................................................................................................................................................... 9801 II
The company plans to manufacture Dated: November 16, 2018. SUMMARY: The registrant listed below
bulk active pharmaceutical ingredients John J. Martin, has applied for and has been granted
(APIs) and reference standards for Assistant Administrator. registration by the Drug Enforcement
distribution to their customers. [FR Doc. 2018–25874 Filed 11–26–18; 8:45 am] Administration (DEA) as an importer of
In reference to drug codes 7360 BILLING CODE 4410–09–P schedule I or II controlled substances.
(marihuana) and 7370 SUPPLEMENTARY INFORMATION: The
(tetrahydrocannabinols), the company company listed below applied to be
DEPARTMENT OF JUSTICE
plans to bulk manufacture these drugs registered as an importer of various
as synthetic. No other activities for these Drug Enforcement Administration basic classes of controlled substances.
drug codes are authorized for this Information on the previously published
[Docket No. DEA–392]
amozie on DSK3GDR082PROD with NOTICES1
registration. notice is listed in the table below. No
Importer of Controlled Substances comments or objections were submitted
Registration and no requests for a hearing were
submitted for this notice.
ACTION: Notice of registration.
VerDate Sep<11>2014 17:45 Nov 26, 2018 Jkt 247001 PO 00000 Frm 00078 Fmt 4703 Sfmt 4703 E:\FR\FM\27NON1.SGM 27NON1](https://thefederalregister.org/doc/83_FR_61126/page/1.svg)
Document Created: 2018-11-27 01:24:11
Document Modified: 2018-11-27 01:24:11
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice of application. | |
| Dates | Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before January 28, 2019. | |
| FR Citation | 83 FR 60898 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR